Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1, 1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents
J Wrobel, A Dietrich, SA Woolson, J Millen…
Index: Wrobel, Jay; Dietrich, Arlene; Woolson, Shiela A.; Millen, Jane; McCaleb, Michael; et al. Journal of Medicinal Chemistry, 1992 , vol. 35, # 24 p. 4613 - 4627
Full Text: HTML
Citation Number: 45
Abstract
Compounds from two novel series of spirosuccinimides were prepared. Analogs of series 2 possessed a spiro-fused isoindolone moiety while those of series 3 contained a spiro-fused benzisothiazole S, S-dioxide group. These compounds were evaluated as aldose reductase inhibitors (ARI) in vitro by their ability to inhibit glyceraldehyde reduction using a partially purified bovine lens aldose reductase preparation and in vivo as inhibitors of galactitol ...
Related Articles:
TiCl4-mediated direct N-alkylation of sulfonamides with inactive ethers
[Chen, Jiayan; Dang, Ling; Li, Qiang; Ye, Yong; Fu, Shaomin; Zeng, Wei Synlett, 2012 , # 4 p. 595 - 600]
[Kim, Sung-Kyu; Moon, Jung-Gyen; Lee, Sang-Gyeong; Choi, Sam-Young; Cho, Su-Dong; et al. Journal of Heterocyclic Chemistry, 1993 , vol. 30, # 2 p. 353 - 356]